Eli Lilly and Novo Nordisk dominate the billion-dollar weight loss drug market. Lilly has announced positive trial results ...

Eli Lilly GLP-1 pill orforglipron could revolutionize the weight loss world by the end of 2025 after promising Phase 3 trial ...

Did Eli Lilly just say checkmate to Novo Nordisk? Let's find out. Image source: Getty Images. So, first a quick bit about how this class of drugs works ... Administration's drug shortage list ...

Did Eli Lilly just say checkmate to Novo Nordisk? Let's find out. So, first a quick bit about how this class of drugs works ... Administration's drug shortage list -- and they only exited the ...

But the latest data from Eli Lilly gives them an edge. "We'll be ready. We're gonna make this medicine here in the ... We've added you to our mailing list.

The India launch of Eli Lilly's popular weight-loss drug Mounjaro has triggered a huge wave of patient enquiries about its ...

Below is a look at some of the most advanced oral obesity drugs. This is not intended to be a comprehensive list. Next on tap for Eli Lilly is data from the Phase 3 ATTAIN program in obesity.

President Donald Trump has ordered the Department of Health and Human Services to standardize Medicare payments in an effort ...

We recently published a list of the 13 Best American Dividend Stocks to Buy According to Analysts. In this article, we are ...

We recently published a list of the 10 Innovative Healthcare Stocks to Watch in 2025. In this article, we are going to take a ...

Pharmaceutical company Eli Lilly’s study of its tablet, orforglipron, has raised hopes of an effective and easy-to-use ...